Kourosh Saeb-Parsy

Title: Kourosh Saeb-Parsy: Innovator in Cholangiocyte Research

Introduction

Kourosh Saeb-Parsy is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of medical research, particularly in the expansion of cholangiocytes. With a total of 2 patents, his work has the potential to impact various medical applications.

Latest Patents

Saeb-Parsy's latest patents include innovative methods for expanding cholangiocytes. The first patent focuses on the expansion of primary cholangiocytes in the form of cholangiocyte organoids (COs). This invention utilizes culture conditions that inhibit canonical Wnt signaling while potentiating non-canonical Wnt/PCP signaling. The second patent involves succinate dehydrogenase inhibitors (SDHi's), which are designed for the treatment or prevention of reperfusion injury, such as ischemia-reperfusion injury. This invention aims to inhibit the accumulation of succinate through a cell-permeable reversible inhibitor of succinate dehydrogenase.

Career Highlights

Throughout his career, Kourosh Saeb-Parsy has worked with notable organizations, including Cambridge Enterprise Limited. His research has garnered attention for its innovative approaches to medical challenges.

Collaborations

Some of his notable coworkers include Ludovic Vallier and Nicholas Hannan. Their collaborative efforts have contributed to advancing research in their respective fields.

Conclusion

Kourosh Saeb-Parsy's contributions to cholangiocyte research and his innovative patents highlight his role as a significant inventor in the medical field. His work continues to pave the way for advancements in medical treatments and applications.